Cargando…
Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia
The benefits of treatment with antiviral therapy for severe adenovirus (AdV) pneumonia are not well established. We described the clinical characteristics and treatment outcomes of early cidofovir treatment of severe AdV pneumonia in non-immunocompromised patients. We retrospectively reviewed the me...
Autores principales: | Kim, Se Jin, Kim, Kang, Park, Sung Bum, Hong, Duck Jin, Jhun, Byung Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398328/ https://www.ncbi.nlm.nih.gov/pubmed/25875735 http://dx.doi.org/10.1371/journal.pone.0122642 |
Ejemplares similares
-
Early cidofovir administration might be associated with a lower probability of respiratory failure in treating human adenovirus pneumonia: a retrospective cohort study
por: Ko, J.-H., et al.
Publicado: (2020) -
Characteristics of Adenovirus Pneumonia in Korean Military Personnel, 2012–2016
por: Yoon, Hee, et al.
Publicado: (2017) -
Adenovirus pneumonia treated with Cidofovir in an immunocompetent high school senior
por: Yoon, Hee-Young, et al.
Publicado: (2019) -
Severe community acquired adenovirus pneumonia in an immunocompetent host successfully treated with IV Cidofovir
por: Zhao, Joseph, et al.
Publicado: (2020) -
Use of cidofovir in pediatric patients with adenovirus infection
por: Ganapathi, Lakshmi, et al.
Publicado: (2016)